Alaunos Therapeutics to Participate in Upcoming Investor Conferences in SeptemberGlobeNewsWire • 09/07/22
These Are The Five Best And Worst Performing Penny Stocks Of 2022 (So Far)24/7 Wall Street • 09/03/22
Alaunos Therapeutics to Present at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy ConferenceGlobeNewsWire • 08/24/22
Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/15/22
Alaunos Therapeutics to Report Second Quarter 2022 Financial Results on August 15, 2022GlobeNewsWire • 08/08/22
Alaunos Therapeutics Appoints Abhishek Srivastava, Ph.D. as Vice President, Technical OperationsGlobeNewsWire • 08/04/22
Alaunos Therapeutics to Present Trials in Progress Poster for its TCR-T Library Phase 1/2 trial at the 2022 American Society of Clinical Oncology Annual MeetingGlobeNewsWire • 05/26/22
Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/16/22